Department of Chemical Sciences, University of Naples Federico II, Complesso Universitario Monte S. Angelo, via Cintia 4, I-80126 Napoli, Italy.
Department of Sciences, University of Basilicata, viale dell'Ateneo Lucano 10, I-85100 Potenza, Italy.
Mar Drugs. 2020 Jun 1;18(6):293. doi: 10.3390/md18060293.
Fucosylated chondroitin sulfate (fCS) is a glycosaminoglycan (GAG) polysaccharide with a unique structure, displaying a backbone composed of alternating -acetyl-d-galactosamine (GalNAc) and d-glucuronic acid (GlcA) units on which l-fucose (Fuc) branches are installed. fCS shows several potential biomedical applications, with the anticoagulant activity standing as the most promising and widely investigated one. Natural fCS polysaccharides extracted from marine organisms (, ) present some advantages over a largely employed antithrombotic drug such as heparin, but some adverse effects as well as a frequently found structural heterogeneity hamper its development as a new drug. To circumvent these drawbacks, several efforts have been made in the last decade to obtain synthetic and semi-synthetic fCS oligosaccharides and low molecular weight polysaccharides. In this Review we have for the first time collected these reports together, dividing them in two topics: (i) total syntheses of fCS oligosaccharides and (ii) semi-synthetic approaches to fCS oligosaccharides and low molecular weight polysaccharides as well as glycoclusters displaying multiple copies of fCS species.
岩藻糖基硫酸软骨素(fCS)是一种具有独特结构的糖胺聚糖(GAG)多糖,其主链由交替的 N-乙酰-d-半乳糖胺(GalNAc)和 d-葡萄糖醛酸(GlcA)单元组成,其上安装有 l-岩藻糖(Fuc)支链。fCS 显示出多种潜在的生物医学应用,其中抗凝活性是最有前途和广泛研究的一种。从海洋生物中提取的天然 fCS 多糖(,)相对于广泛使用的抗血栓药物肝素具有一些优势,但也存在一些不良反应和经常发现的结构异质性,这阻碍了其作为新药的开发。为了克服这些缺点,过去十年中已经做出了一些努力来获得合成和半合成的 fCS 低聚糖和低分子量多糖。在这篇综述中,我们首次将这些报道汇集在一起,将它们分为两个主题:(i)fCS 低聚糖的全合成,以及(ii)fCS 低聚糖和低分子量多糖以及展示多个 fCS 物种的糖缀合物的半合成方法。